17 January 2017
News and Views
Links and Services
Proton pump inhibitor use may not prevent high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus, reports May's publication of the Alimentary Pharmacology & Therapeutics.
Proton pump inhibitors (PPI) may potentially modify and decrease the risk for development of esop
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors